IFLO and THRX Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IFLO and THRX

THRX 9.810

+0.4%

Jan 8 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brian Nichols who wrote (57)	12/8/1996 7:09:00 PM
From: RODNEY W. CURVIN	of 68

HELLO BRIAN, THRX IS A MOST KILLER STOCK. THE COMPANY EXPANDS ITS CAPACITY AT AN ALMOST REGULAR PACE. IT WAS A DOUBLER FOR ME THIS YEAR. I HAVE SOLD MY POSITIONS THOUGH. I'M WAITING FOR A SERIOUS DIP BEFORE REBUYING. IF MEDICAL TECH COMPANIES INTEREST YOU, YOU MIGHT LOOK INTO SYNCOR (SCOR). THEY HAVE A GROWING ESTABLISHED RADIOPHARMACUETICAL BUSINESS. THEIR POTENTIAL LIES IN THEIR POSITRON EMISSION TOMOGRAPHY (PET) WILD CARD. EARNINGS AT SCOR WILL BE DAMPENED DUE TO THEIR INVESTMENT IN PET; HOWEVER IMO THE SALES FROM PET AND FDG (THE RADIOISOTOPE COCKTAIL USED TO PRODUCE THE IMAGING) SHOULD BLOSSOM NICELY TO COUNTERACT. PER IND. INVESTOR SYNCOR'S CORE BUSINESS IS WORTH OVER $10/SHR. YOU MAY HAVE A CHANCE TO BET ON PET WITH LITTLE DOWNSIDE POTENTIAL. BY THE WAY I WAS A BUYER OF SCOR BEFORE THE MAGIC 25 FEATURE. RODNIUS

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next